The Effect of Diabetes Mellitus in Colonoscopy Under Sedoanalgesia

Sponsor
Baskent University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04477694
Collaborator
(none)
100
1
24.1
4.2

Study Details

Study Description

Brief Summary

INTRODUCTION AND AIM Diabetes Mellitus (DM) is a common endocrine disease in the world. Colon polyps and colorectal cancers are reported more in DM patients. Therefore diabetic patients are recommended to have colonoscopy frequently. The aim of this study is to search the effect of DM on hemodynamics, procedure times, anesthetic consumption and complications in colonoscopy under sedoanalgesia.

MATERIALS AND METHODS Following Institutional Review Board and Ethics Committee approval of Başkent University, this study is planned to be prospective and double-blind in 50 type II diabetic and 50 non-diabetic ASA I-II, aged between 18-65 years female patients scheduled for elective colonoscopy under sedoanalgesia. Exclusion criteria are age outside the range of 18-65 years, ASA phsical status ≥ 3, inability to provide informed consent, pregnancy, previous adverse reactions to medications used in the study, history of anesthesia and sedation in the last 7 days, psychiatric or emotional disorders, addiction to the opioids or sedatives used in the study, diabetic nephrophathy, high BUN and creatinine values, advanced stages of diabetic nonalcoholic liver disease and high liver function tests, diabetic sensorymotor and autonomic neuropathy.

After sedoanalgesia is applied systolic and diastolic blood pressure, heart rate, SpO2, respiratory rate, RSS, MPADS, procedure times, total anesthetic doses, stomach ache and other effects will be recorded.

EXPECTATIONS AND SCIENTIFIC CONTRIBUTIONS There is evidence about determining the risks that diabetic patients have during colonoscopy and applying a special patient care protocol for these patients is suggested to improve the procedure and outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: colonoscopy under sedoanalgesia

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Effect of Diabetes Mellitus on Hemodynamics, Procedure Times, Anesthetic Consumption and Complications in Colonoscopy Under Sedoanalgesia
Actual Study Start Date :
Dec 27, 2020
Anticipated Primary Completion Date :
Nov 30, 2022
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
type II diabetic patients

Procedure: colonoscopy under sedoanalgesia
Colonoscopy is a widely used method for diagnosing and treating colonic diseasea with a thin, flexible camera.

non-diabetic patients

Procedure: colonoscopy under sedoanalgesia
Colonoscopy is a widely used method for diagnosing and treating colonic diseasea with a thin, flexible camera.

Outcome Measures

Primary Outcome Measures

  1. Comparison of mean blood pressure in diabetic and non-diabetic patients in colonoscopy under sedoanalgesia [24 hour]

    After sedoanalgesia is applied mean blood pressure will be recorded.

  2. Comparison of heart rate in diabetic and non-diabetic patients in colonoscopy under sedoanalgesia [24 hour]

    After sedoanalgesia is applied heart rate will be recorded.

  3. Comparison of SpO2 in diabetic and non-diabetic patients in colonoscopy under sedoanalgesia [24 hour]

    After sedoanalgesia is applied SpO2 will be recorded.

  4. Comparison of respiratuar rate in diabetic and non-diabetic patients in colonoscopy under sedoanalgesia [24 hour]

    After sedoanalgesia is applied respiratuar rate will be recorded.

  5. Comparison of Ramsay sedation score level in diabetic and non-diabetic patients in colonoscopy under sedoanalgesia [24 hour]

    After sedoanalgesia is applied Ramsay sedation score level will be recorded. Ramsay sedation score level will be 3 during the process. When the score level is 2, at the end of the procedure, it will be taken to the postoperative intensive care unite.

  6. Comparison of Modified post anaesthetic discharge score level in diabetic and non-diabetic patients in colonoscopy under sedoanalgesia [24 hour]

    After sedoanalgesia is applied modified post anaesthetic discharge score level will be recorded. Patients will be discharged when the score level is 9 or above.

  7. Comparison of procedure times in diabetic and non-diabetic patients in colonoscopy under sedoanalgesia [24 hour]

    After sedoanalgesia is applied procedure times will be recorded.

  8. Comparison of total anaesthetic doses in diabetic and non-diabetic patients in colonoscopy under sedoanalgesia [24 hour]

    After sedoanalgesia is applied total anaesthetic doses will be recorded.

  9. Comparison of stomach ache and other effects in diabetic and non-diabetic patients in colonoscopy under sedoanalgesia [24 hour]

    After sedoanalgesia is applied stomach ache and other effects will be recorded. Stomach ache will be evaluated by visuel analog pain scale. When it is 4 or above, will be considered meaningful.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Female patients aged between 18-65 years old

  • Type II diabetic and non-diabetic

Exclusion Criteria:
  • Age outside the range of 18-65 years

  • ASA phsical status ≥ 3

  • Inability to provide informed consent

  • Pregnancy

  • Previous adverse reactions to medications used in the study

  • History of anesthesia and sedation in the last 7 days

  • Psychiatric or emotional disorders

  • Addiction to the opioids or sedatives used in the study

  • Diabetic nephrophathy, high BUN and creatinine values

  • Advanced stages of diabetic nonalcoholic liver disease and high liver function tests

  • Diabetic sensorymotor and autonomic neuropathy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Baskent University Zubeyde Hanim Practice and Research Center İzmir Karşıyaka Turkey 35540

Sponsors and Collaborators

  • Baskent University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yonca Özvardar Pekcan, MD, Anesthesia and Reanimation specialist, principal Investigator, Baskent University
ClinicalTrials.gov Identifier:
NCT04477694
Other Study ID Numbers:
  • K19/320
First Posted:
Jul 20, 2020
Last Update Posted:
Aug 24, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yonca Özvardar Pekcan, MD, Anesthesia and Reanimation specialist, principal Investigator, Baskent University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2022